CN1424041A - Kakonein preparations and their production - Google Patents
Kakonein preparations and their production Download PDFInfo
- Publication number
- CN1424041A CN1424041A CN 02155198 CN02155198A CN1424041A CN 1424041 A CN1424041 A CN 1424041A CN 02155198 CN02155198 CN 02155198 CN 02155198 A CN02155198 A CN 02155198A CN 1424041 A CN1424041 A CN 1424041A
- Authority
- CN
- China
- Prior art keywords
- puerarin
- poloxamer
- polyethylene glycol
- stir
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
本发明是一种葛根素滴丸制剂及其制备方法。该滴丸制剂以葛根素为主要成份,与聚乙二醇、泊洛沙姆按一定工艺组配制成。本发明的滴丸制剂与其余剂相比,药物起效快、生物利用度高,制备工艺适合于工业化生产。The invention relates to a puerarin dripping pill preparation and a preparation method thereof. The dropping pill preparation takes puerarin as the main component, and is prepared according to a certain process group with polyethylene glycol and poloxamer. Compared with other preparations, the dropping pill preparation of the present invention has quick drug onset and high bioavailability, and the preparation process is suitable for industrialized production.
Description
Technical field
The invention belongs to medical technical field, being specifically related to a kind of is oral solid formulation of main component and preparation method thereof with puerarin (Puerarin), is a kind of puerarin dropping pill formulation and preparation method thereof specifically.
Background technology
Puerarin has pharmacological action comparatively widely; experimental results show that puerarin has dilating effect to coronary artery; can protect global ischemia cardiac muscle and myocardial ischemia reperfusion injury; reduce the acute myocardial infarction area; reduce myocardial oxygen consumption; prevent platelet adhesion, gathering and thrombosis, puerarin has significant protective effect to acute cerebral ischemia, and B-adrenergic receptor is had blocking effect.Clinically, puerarin is mainly used in the treatment of diseases such as coronary heart disease, angina pectoris, myocardial infarction, ischemic cerebrovascular, sudden deafness, retina artery and vein obstruction.
At present the preparation of puerarin is in the majority with injection clinically, for example puerarin glucose injection, puerarin sodium chloride injection etc., and injection exists the shortcoming of patient's medication inconvenience when curative effect can be affirmed.At present the solid preparation of puerarin has only tablet, because the dissolubility of puerarin is bad, and the performance that tablet exists as problems affect curative effects such as absorbing slowly, bioavailability is little, and coronary heart disease, angina pectoris belong to clinical acute disease, rapid onset needs first aid.
Summary of the invention
The object of the present invention is to provide a kind of drug effect is fast, bioavailability is high oral puerarin dropping pill formulation and preparation method.
The puerarin dropping pill formulation that the present invention proposes, be a kind of oral solid formulation, it is Main Ingredients and Appearance with the puerarin, with Polyethylene Glycol (requiring its molecular weight greater than 1500) and poloxamer is that the compatibility component is formulated, the weight proportion of each component is: 1 part of puerarin, Polyethylene Glycol 2.5-6.5 part, poloxamer 0.5-2.0 part.
The puerarin dropping pill formulation that the present invention proposes, its preferred component weight proportion is: 1 part of puerarin, Polyethylene Glycol 3-5 part, poloxamer 0.5-1 part.
The primary structure formula of Main Ingredients and Appearance puerarin of the present invention is a following formula I:
Formula I
The preparation method of the puerarin dropping pill formulation that the present invention proposes is as follows: by the weight proportion of each component Polyethylene Glycol, poloxamer are placed in the water-bath and heat, make it fusion; Add puerarin, stir, add anhydrous alcohol for medical use, stir hydrotropy; Continue to stir volatilization ethanol, 85~100 ℃ of heat preservation for standby use; Preheating DW-1 type drop pill machine, making fluid storage compartment constant temperature is fluid temperature, the coolant soybean oil is chilled to 10~12 ℃ in advance, drips system with 28~32 droplets/minute the speed of dripping; Collect drop pill at valve port, the filtering coolant, and absorb surperficial oil stain, and dry, promptly get the molding drop pill.
The puerarin dropping pill formulation that the present invention makes has the advantage that drug effect is fast, bioavailability is high, and its process conditions advanced person, is fit to the characteristics of industrial-scale production.The tablet of puerarin is just stripping 18% in 45 minutes in 0.3% sodium dodecyl sulfate solution, and the stripping in 15 minutes under identical leaching condition of puerarin drop pill is complete, can guarantee that thus the onset of puerarin drop pill is faster than tablet.
The specific embodiment
Further specifically describe the present invention below by embodiment.
Embodiment 1:
The weight proportion of puerarin drop pill each component is:
Puerarin 6.25g
Polyethylene Glycol (6000) 25.66g
Poloxamer (188) 5.50g
The method for preparing the puerarin drop pill is as follows:
Polyethylene glycol 6000 25.66g, poloxamer 1885.50g are placed in the water-bath and heat, make it fusion; Add the 6.25g puerarin, stir, add anhydrous alcohol for medical use 3.67ml, stir hydrotropy, continue to stir, volatilization ethanol, 95 ℃ of heat preservation for standby use; With the preheating of drop pill machine, fluid storage compartment constant temperature is 95 ℃ ± 2 ℃, and the coolant soybean oil is chilled to 10~12 ℃ in advance, regulates drip nozzle and the distance of cooling off liquid level, pours medicinal liquid into fluid storage compartment, starts valve, and medicinal liquid is dropwise splashed in the coolant, drips speed and is about 30 droplets/minute; Open and collect a mouthful valve, collect drop pill, gauze filtering coolant, and absorb surperficial remaining oil stain, and spread out, dry, promptly get the drop pill of molding.
Embodiment 2:
The weight proportion of puerarin drop pill each component is:
Puerarin 8.05g
Polyethylene Glycol (4000) 20.13g
Poloxamer (188) 16.10g
The method for preparing the puerarin drop pill is as follows:
Polyethylene Glycol (4000) 20.13g, poloxamer (188) 16.10g are placed in the water-bath and heat, make fusion; Add the 8.05g puerarin, stir, add anhydrous alcohol for medical use 4.57ml, stir hydrotropy, continue to stir, volatilization ethanol, 88 ℃ of heat preservation for standby use; With the preheating of drop pill machine, fluid storage compartment constant temperature is 90 ℃ ± 2 ℃, and the coolant soybean oil is chilled to 10~12 ℃ in advance, regulates drip nozzle and the distance of cooling off liquid level, pours medicinal liquid into fluid storage compartment, starts valve, and medicinal liquid is dropwise splashed in the coolant, drips speed and is about 28 droplets/minute; Open and collect a mouthful valve, collect drop pill, gauze filtering coolant, and absorb surperficial remaining oil stain, and spread out, dry, promptly get the drop pill of molding.
Embodiment 3:
The weight proportion of puerarin drop pill each component is:
Puerarin 4.35g
Polyethylene Glycol (1500) 26.10g
Poloxamer (188) 6.53g
The method for preparing the puerarin drop pill is as follows:
Polyethylene Glycol (1500) 26.10g, poloxamer (188) 6.53g are placed in the water-bath and heat, make fusion; Add the 4.35g puerarin, stir, add anhydrous alcohol for medical use 5.32ml, stir hydrotropy, continue to stir, volatilization ethanol, 98 ℃ of heat preservation for standby use; With the preheating of drop pill machine, fluid storage compartment constant temperature is 98 ℃ ± 2 ℃, and the coolant soybean oil is chilled to 10~12 ℃ in advance, regulates drip nozzle and the distance of cooling off liquid level, pours medicinal liquid into fluid storage compartment, starts valve, and medicinal liquid is dropwise splashed in the coolant, drips speed and is about 32 droplets/minute; Open and collect a mouthful valve, collect drop pill, gauze filtering coolant, and absorb surperficial remaining oil stain, and spread out, dry, promptly get the drop pill of molding.
Embodiment 4:
The weight proportion of puerarin drop pill each component is:
Puerarin 6.40g
Polyethylene Glycol (6000) 25.60g
Poloxamer (188) 12.8g
The method for preparing the puerarin drop pill is as follows:
Polyethylene Glycol (6000) 6.40g, poloxamer (188) 12.8g are placed in the water-bath and heat, make fusion; Add the 6.40g puerarin, stir, add anhydrous alcohol for medical use 7.08ml, stir hydrotropy, continue to stir, volatilization ethanol, 95 ℃ of heat preservation for standby use; With the preheating of drop pill machine, fluid storage compartment constant temperature is 95 ℃ ± 2 ℃, and the coolant soybean oil is chilled to 10~12 ℃ in advance, regulates drip nozzle and the distance of cooling off liquid level, pours medicinal liquid into fluid storage compartment, starts valve, and medicinal liquid is dropwise splashed in the coolant, drips speed and is about 30 droplets/minute; Open and collect a mouthful valve, collect drop pill, gauze filtering coolant, and absorb surperficial remaining oil stain, and spread out, dry, promptly get the drop pill of molding.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02155198 CN1424041A (en) | 2002-12-19 | 2002-12-19 | Kakonein preparations and their production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02155198 CN1424041A (en) | 2002-12-19 | 2002-12-19 | Kakonein preparations and their production |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1424041A true CN1424041A (en) | 2003-06-18 |
Family
ID=4752577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02155198 Pending CN1424041A (en) | 2002-12-19 | 2002-12-19 | Kakonein preparations and their production |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1424041A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100364533C (en) * | 2005-04-19 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | Pyrolidone hydrochloride drip pill and its preparation method |
CN100364537C (en) * | 2005-03-28 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | Cepharanthine drip pill and its preparation method |
CN100453072C (en) * | 2005-01-28 | 2009-01-21 | 北京正大绿洲医药科技有限公司 | Banlangen dripping pills and preparation method thereof |
CN1615899B (en) * | 2003-11-13 | 2010-05-05 | 中国人民解放军军事医学科学院毒物药物研究所 | Puerarin oral preparation |
CN101804045A (en) * | 2010-04-09 | 2010-08-18 | 上海新康制药厂 | Application of puerarin |
CN101569614B (en) * | 2009-06-08 | 2011-03-30 | 成都医学院 | A kind of puerarin-coated slow-release dropping pill and preparation method thereof |
CN104622828A (en) * | 2015-01-07 | 2015-05-20 | 太原工业学院 | Preparation method of puerarin sustained-release dropping pill |
-
2002
- 2002-12-19 CN CN 02155198 patent/CN1424041A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1615899B (en) * | 2003-11-13 | 2010-05-05 | 中国人民解放军军事医学科学院毒物药物研究所 | Puerarin oral preparation |
CN100453072C (en) * | 2005-01-28 | 2009-01-21 | 北京正大绿洲医药科技有限公司 | Banlangen dripping pills and preparation method thereof |
CN100364537C (en) * | 2005-03-28 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | Cepharanthine drip pill and its preparation method |
CN100364533C (en) * | 2005-04-19 | 2008-01-30 | 北京正大绿洲医药科技有限公司 | Pyrolidone hydrochloride drip pill and its preparation method |
CN101569614B (en) * | 2009-06-08 | 2011-03-30 | 成都医学院 | A kind of puerarin-coated slow-release dropping pill and preparation method thereof |
CN101804045A (en) * | 2010-04-09 | 2010-08-18 | 上海新康制药厂 | Application of puerarin |
CN104622828A (en) * | 2015-01-07 | 2015-05-20 | 太原工业学院 | Preparation method of puerarin sustained-release dropping pill |
CN104622828B (en) * | 2015-01-07 | 2017-10-13 | 太原工业学院 | A kind of preparation method of puerarin sustained-release dropping pills |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI254634B (en) | Extrusion process for forming chemically stable drug multiparticulates | |
JP4213383B2 (en) | Hydrophilic polymer thin film multilayer drug for rapid release of active ingredients | |
RU2428179C2 (en) | Preparative forms of medications against dementia for transcutaneous introduction | |
KR100459747B1 (en) | Rosesia Therapeutics | |
JP2022116191A (en) | Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization | |
CN1424041A (en) | Kakonein preparations and their production | |
US7737130B2 (en) | Pharmaceutical compositions for topical use in treatment of skin or mucous injuries | |
CN1202816C (en) | Glimepiride dripping pills | |
CN112110889B (en) | Scutellarin aglycone derivative, preparation method and application thereof | |
US20080145318A1 (en) | Atomoxetine formulations and associated methods | |
WO2020190072A1 (en) | Composition for promoting skin wound healing or skin regeneration, containing (r)-ginsenoside rg3 as active ingredient | |
CN102716135A (en) | Application of lupenone to products for preventing or treating diabetes mellitus | |
KR960011240B1 (en) | Drugs for the treatment of heart failure | |
CN109200273B (en) | Application of polypeptide in preparation of medicine for preventing or treating fatty liver disease | |
CN102836211A (en) | Salvia miltiorrhiza-lobed kudzuvine root eyesight improving in-situ gel | |
CN102525991A (en) | Compound preparation containing pioglitazone hydrochloride and metformin hydrochloride and method for preparing compound preparation containing pioglitazone hydrochloride and metformin hydrochloride | |
CN101404981A (en) | Methods and compositions for treatment of diastolic heart failure | |
CN105777712B (en) | Tetrahydroisoquinoliderivs derivs and its application | |
CN100364533C (en) | Pyrolidone hydrochloride drip pill and its preparation method | |
JPH0358923A (en) | Treating diabetes mellitus | |
CN110327354B (en) | Application of diosgenin in treatment and prevention of psoriasis | |
CN110496115B (en) | Metformin ionic liquid and preparation and application thereof | |
CN1258364C (en) | Formula of calebassine dripping pills and its preparation method | |
JP5164407B2 (en) | Peripheral circulation improving drug | |
CN1449765A (en) | Puerarin soft capsule pharmaceutics and preparation process thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |